MedTrace Logo

Head and Neck Cancer Screening and Serum Repository

NCT00592371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2012-09-05

No results posted yet for this study

Summary

Head and Neck Squaumous Cell Cancer(HNSCC) is the 6th most common cancer in the United States and the 3rd most common worldwide. Risk factors include abuse to tobacco and alcohol. Survival is related to stage of HNSCC when treatment is sought. Most HNSCC patients present with advanced staged disease. This screening activity will educate patients with HNSCC rick factors and screen for pre malignant and/or early staged lesions.

Conditions

  • Head and Neck Squamous Cell Cancer

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Brendan Stack, MD · University of Arkansas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592371 on ClinicalTrials.gov